[{"innerBlocks":[],"name":"core\/freeform","postId":860,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"Patients with chronic obstructive pulmonary disease experience exacerbations caused by an infection in the lung. But a novel technique is being studied by Geisinger Health System to detect these flare-ups.

Geisinger\u2019s Voice Analysis of COPD Patients with Exacerbations (VOICE) study, supported by a grant from pharmaceutical company GlaxoSmithKline, will evaluate an algorithm for vocal biomarkers that gives clinicians the ability to assess the voice of their patients wherever and whenever they speak on their smartphones.

Also See<\/b>: Risk score uses EHR data to predict COPD patient outcomes<\/a>

The algorithm, developed by Israeli artificial intelligence vendor Healthymize, transforms smartphones into remote patient monitoring devices for voice-affecting diseases such as asthma, COPD and pneumonia.

Healthymize analyzes voice samples from patients to identify the onset of flare-ups\u2014characterized by shortness of breath, coughing and sputum production\u2014to provide treatment and prevent deterioration of their condition and prevent hospitalization.

\u201cIf we detect changes in a patient\u2019s health condition earlier, we can reduce hospitalization and administer care in a timely manner at home,\u201d says Paul F. Simonelli, MD, principal investigator of the study and chair of the Department of Pulmonary and Critical Care Medicine at Geisinger. \u201cWe know that early detection of exacerbation improves outcomes, and Healthymize has the potential to present an easy-to-use solution that monitors patients from home.\u201d

Currently, Geisinger is recruiting patients between the ages of 40 and 80 who have a prior year history of COPD exacerbations including bronchitis or pneumonia. Participants will be required to perform daily voice recordings and questionnaires over a six-month period.

\u201cHealthymize can start with COPD and then expand to other chronic care concerns, such as heart disease and mental health issues,\u201d adds Simonelli.","saveContent":"Patients with chronic obstructive pulmonary disease experience exacerbations caused by an infection in the lung. But a novel technique is being studied by Geisinger Health System to detect these flare-ups.

Geisinger\u2019s Voice Analysis of COPD Patients with Exacerbations (VOICE) study, supported by a grant from pharmaceutical company GlaxoSmithKline, will evaluate an algorithm for vocal biomarkers that gives clinicians the ability to assess the voice of their patients wherever and whenever they speak on their smartphones.

Also See<\/b>: Risk score uses EHR data to predict COPD patient outcomes<\/a>

The algorithm, developed by Israeli artificial intelligence vendor Healthymize, transforms smartphones into remote patient monitoring devices for voice-affecting diseases such as asthma, COPD and pneumonia.

Healthymize analyzes voice samples from patients to identify the onset of flare-ups\u2014characterized by shortness of breath, coughing and sputum production\u2014to provide treatment and prevent deterioration of their condition and prevent hospitalization.

\u201cIf we detect changes in a patient\u2019s health condition earlier, we can reduce hospitalization and administer care in a timely manner at home,\u201d says Paul F. Simonelli, MD, principal investigator of the study and chair of the Department of Pulmonary and Critical Care Medicine at Geisinger. \u201cWe know that early detection of exacerbation improves outcomes, and Healthymize has the potential to present an easy-to-use solution that monitors patients from home.\u201d

Currently, Geisinger is recruiting patients between the ages of 40 and 80 who have a prior year history of COPD exacerbations including bronchitis or pneumonia. Participants will be required to perform daily voice recordings and questionnaires over a six-month period.

\u201cHealthymize can start with COPD and then expand to other chronic care concerns, such as heart disease and mental health issues,\u201d adds Simonelli.","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

Geisinger COPD study to test vocal biomarker algorithm

More for you